Veterinary Artificial Insemination Market
Number of pages: 100 | Report Format: PDF | Published date: April 10, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 5.03 billion |
|
Revenue Forecast in 2031 |
US$ 8.28 billion |
|
CAGR |
5.7% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Animal Type, Product, End-user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global veterinary artificial insemination market was valued at US$ 5.03 billion in 2022 and is expected to register a revenue CAGR of 5.7% to reach US$ 8.28 billion by 2031.
Veterinary Artificial Insemination Market Fundamentals
Veterinary artificial insemination (AI) is a reproductive technique used in animals where sperm is collected from a male animal and introduced into the reproductive tract of a female animal to fertilize her eggs. The process is carried out with the help of specialized equipment and techniques. It can be performed on various animal species, including cattle, horses, ovine & caprine, equine, swine, dogs, and cats. The process typically involves collecting semen from a male animal using techniques such as electroejaculation or an artificial vagina. The semen is then processed and prepared for insemination, which can be performed either by depositing the semen directly into the female's reproductive tract using a catheter or by using a specialized device such as an insemination gun or pipette.
Artificial insemination can be used for various reasons, including selective breeding for desirable traits such as improved meat quality or milk production, genetic preservation, and to treat infertility or other reproductive issues. It is often considered a safer and more controlled breeding method than natural breeding, as it reduces the risk of injury to the animals and the transmission of certain diseases. It can also be more cost-effective than natural breeding, particularly in large-scale animal husbandry operations. Veterinary artificial insemination is a valuable reproductive technique for improved animal breeding outcomes, genetic preservation, and disease control.
[67555]
Veterinary Artificial Insemination Market Dynamics
As the global population continues to grow, there is an increasing demand for animal protein, dairy products, and meat. This has led to an increase in animal husbandry, which in turn drives demand for the global veterinary artificial insemination market demand. Advances in veterinary reproductive technologies, including artificial insemination, have made it easier and more efficient to breed animals, which helps in boosting the revenue growth of veterinary artificial insemination services. Additionally, animal disease prevalence is increasing, leading to a growing demand for veterinary reproductive services, including artificial insemination. Consumers are becoming more aware of animal welfare and are demanding higher standards for the treatment of animals. Veterinary artificial insemination offers a more humane way of breeding animals than traditional methods. Moreover, government organizations in several countries are providing support and incentives for adopting artificial insemination in animal breeding which has further fueled the revenue growth of the global veterinary artificial insemination market.
However, veterinary artificial insemination can be expensive compared to natural breeding methods. This cost can be a major restraint for many farmers and animal breeders, especially in developing countries. Moreover, the success of artificial insemination depends on the skills of the professional performing the procedure. There is often a shortage of skilled professionals in many regions, limiting the availability of artificial insemination services. Furthermore, using artificial insemination can lead to reduced genetic diversity within animal populations, increasing the risk of genetic disorders and reducing the population's overall health. Additionally, lack of awareness and education and limited genetic diversity are some of the restraints impeding the overall market revenue growth.
Veterinary Artificial Insemination Market Ecosystem
The global veterinary artificial insemination market is analyzed from four perspectives: animal type, product, end-user, and region.
Veterinary Artificial Insemination Market by Animal Type
[89544]
Based on the animal type, the global veterinary artificial insemination market is segmented into cattle, swine, ovine & caprine, horses, and others.
The cattle segment dominated the market with the principal revenue share in 2022, attributed to the demand for good quality meat and dairy products. The cattle segment refers to the use of artificial insemination techniques in the breeding and reproduction of cattle. Cattle are a major focus of the veterinary artificial insemination market, as they are commonly used for meat and dairy production, and selective breeding can significantly impact the quality and productivity of these operations. The use of artificial insemination in the cattle segment requires specialized equipment and techniques to collect and process semen from the male animals and to inseminate the female animals properly. Factors such as the timing of insemination, the quality of the semen, and the health of the animals can all influence the success rates of artificial insemination.
Additionally, artificial insemination offers a more efficient way to breed cattle compared to natural breeding methods. This can lead to higher productivity and profits for farmers. It also allows for the selective breeding of cattle to improve desirable traits, such as milk production or meat quality. This can help to improve the overall genetic makeup of the cattle population. These factors contribute to the revenue growth of the cattle segment.
Veterinary Artificial Insemination Market by Product
Based on the product, the global veterinary artificial insemination market is segmented into normal semen and sexed semen.
The normal semen segment dominated the market with the largest revenue share in 2022. This source is not sorted for the sex of the offspring and contains a mix of X and Y-chromosome-bearing sperm cells responsible for producing both male and female offspring. Normal semen is often used in animal breeding programs where the sex of the offspring is not a primary concern or where there is a desire to maintain genetic diversity within a population. It is also used in cases where sexed semen is unavailable or where the success rates of sexed semen are lower than those of normal semen. Normal semen is in high demand for artificial insemination procedures, as it is a critical component. Moreover, ongoing research and development in the field of normal semen collection and processing are important to ensure that the quality of the semen is maintained and that the process becomes more efficient and cost-effective. These overall factors contribute to the revenue growth of the normal semen segment.
The sexed semen segment also accounted for a prominent revenue share. In sexed semen, there is the use of specially processed semen that has been sorted to produce offspring of a specific sex. Sexed semen is often used in animal breeding programs to produce offspring of a desired sex, which can be particularly valuable for certain animal species or industries. For example, dairy farmers may prefer female offspring from their cows, as they are typically better milk producers than males. Similarly, in the pork industry, producers may prefer male offspring for their fast growth rates and high meat quality. The use of sexed semen in veterinary artificial insemination requires specialized equipment and techniques to ensure that the sorted sperm cells are viable and properly inseminated into the female animal's reproductive tract. These overall factors contribute to the revenue growth of the sexed semen segment.
Veterinary Artificial Insemination Market by End User
Based on the end user, the global veterinary artificial insemination market is segmented into veterinary hospitals, veterinary husbandry, and others.
The veterinary hospital's segment is a key player in the veterinary artificial insemination market, with the largest revenue share in 2022, being a primary place to go for any animal-related issues. Veterinary hospitals often provide reproductive services to their clients, including artificial insemination, to help manage their animals' breeding and improve their herds' genetic quality. Artificial insemination is a common reproductive service offered by veterinary hospitals, and it can be used for a wide range of animal species, including dogs, cats, horses, cattle, and swine. In veterinary hospitals, both normal and sexed semen can be used depending on the breeding goals of the client. The use of artificial insemination in veterinary hospitals requires specialized equipment and techniques to collect and process semen from male animals and inseminate female animals properly. Factors such as the timing of insemination, the quality of the semen, and the health of the animals can all influence the success rates of artificial insemination. In addition to artificial insemination, veterinary hospitals may offer other reproductive services, such as estrus synchronization, pregnancy diagnosis, and embryo transfer. These services can help clients manage the breeding of their animals more effectively and improve the genetic quality of their herds. These overall factors contribute to the revenue growth of the veterinary hospital's segment.
Veterinary Artificial Insemination Market by Region
Based on region, the global veterinary artificial insemination market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global veterinary artificial insemination market with the largest revenue share in 2022, attributed to a well-equipped animal husbandry sector, increased knowledge and implementation of AI for livestock production, and the existence of major firms. Additionally, companies across the region are continuously involved in mergers, acquisitions, and partnerships, which are also helping in the growth of the region. For instance, in January 2022, the collaboration between Semex and Nedap strengthened and extended, resulting in increased availability of the Semex ai24 program with Nedap technology in more countries. This program enables dairy producers to significantly enhance the performance and profitability of their herds by monitoring cow reproduction, health, and location. Since 2008, the Semex ai24 program has been offered with Nedap technology in several key dairy regions. The growing number of dairy farmers using this technology has reported positive results and high levels of satisfaction. These factors have contributed to the expansion of the program to more regions.
Veterinary Artificial Insemination Market Competitive Landscape
The prominent players operating in the global veterinary artificial insemination market are:
Veterinary Artificial Insemination Market Strategic Developments
A well-equipped animal husbandry sector, increased knowledge and implementation of AI for livestock production, and the existence of major firms are attributing North America to dominate the global veterinary artificial insemination market with the largest revenue share.
Veterinary artificial insemination is a reproductive technique used in animals where sperm is collected from a male animal and introduced into the reproductive tract of a female animal to fertilize her eggs.
The estimated size of the global veterinary artificial insemination market in 2031 is US$ 8.28 billion.
The revenue CAGR of the veterinary artificial insemination market during the forecast period will be 5.7% from 2023 to 2031.
Some prominent players operating in the global veterinary artificial insemination market areElanco Animal Health, Boehringer Ingelheim, Merck & Co., Inc., Shipley Swine Genetics, Zoetis Services LLC, Swine Genetics International, IMV Technologies, Tek-Event Pty Ltd., and Jorgensen Laboratories Inc.
*Insights on financial performance are subject to the availability of information in the public domain